Rotenoids are components of the roots, stems, and leaves of many leguminous species of the genera Derris, Lonchocarpus, Tephrosia, and Amorpha. Rotenone, a prominent component of this group, was first isolated in 1895 (12) , but its structure was established only recently (2, 6, 7, 10) . It is a well-characterized inhibitor of the mitochondrial respiratory chain at the level of NADH dehydrogenase (3) . Rotenoids have been widely used as nonpersistent pesticides because of their effectiveness, selectivity, and apparently low environmental hazard. Although the metabolism of rotenone has been studied in mammals and insects (11, 13) , no studies on the microbial metabolism or transformation of this compound have been reported. Aspects of the chemistry, biochemistry, metabolism, pharmacology, and toxicology of rotenone have been reviewed (13) , and the need for further studies on the metabolism of this compound, including definitive identification of metabolites formed by various species, has been emphasized (13) . This report identifies the products of rotenone and of 1',2'-dihydrorotenone when metabolized by Cunninghamella blakesleeana.
MATERIALS AND METHODS
Organisms and fermentation procedures. The cultures used in this study are maintained in the University of Iowa College of Pharmacy culture collection and are stored in sealed screw-capped tubes at 4°C. Organisms were grown in a medium of the following composition: soybean meal (5 g), glucose (20 g), yeast extract (5 g), NaCl (5 g ), K2HPO4 (5 g), and distilled water (1.0 liter), adjusted to pH 7.0 with 5 N HCI. The media were sterilized in an autoclave at 121°C for 15 min. Microorganisms were grown by a previously described two-stage fermentation procedure (1) . Screening experiments were conducted in 125-ml steelcapped Delong culture flasks containing 25 ml of medium. Substrates (10 mg in 0.1 ml of dimethylformamide) were added to 24-h-old stage II cultures, and 4-ml samples were withdrawn at various time intervals and extracted with 1 ml of ethyl acetate. Samples of approximately 30 1l of the ethyl acetate extracts were examined by thin-layer chromatography (TLC). Con Table 1 , and the 13C-NMR spectrum is given in Table 2 . The Rf value of rotenone on TLC was 0.67 in solvent system B.
Production of metabolites from rotenone. C. blakesleeana ATCC 8688a was grown in the medium mentioned above. Rotenone (12 g) was dissolved in 12 ml of dimethylformamide and distributed evenly among 12 liters of 24-h-old stage II culture flasks. Incubations were monitored by TLC to determine the rate and extent of conversions and were terminated 72 h after substrate addition. At this stage the extent of the conversion of rotenone to compounds 3 and 4 was 20 and 50%, respectively (TLC estimate), and the cultures were harvested. The pooled cultures were extracted exhaustively with ethyl acetate, and the organic phases were combined and dried over anhydrous sodium sulfate and evaporated to dryness under vacuum to yield a brownish oil (12.4 g).
The oil was adsorbed on silica gel and applied as a dry powder to a column (49 by 4.5 cm) containing 200 g of 40-140 mesh silica gel. The column was washed with 250 ml of solvent system C before fraction collection at a flow rate of 4 ml min-1, and then 21-ml fractions were collected. Rotenone was recovered (5.2 g) in fractions 4 through 20, which also contained small amounts of compound 2. Complete separation and purification of the metabolites 3 and 4 and compounds 3a, 4a, and 4b required several passages through silica gel columns with solvent systems C, D, and E. Production and isolation of metabolites from 1',2'-dihydrorotenone. Metabolites of 1',2'-dihydrorotenone were prepared in the same way as above, except that 10 g of 1',2'-dihydrorotenone was added to 11 liters of the 24-h-old stage II culture flasks. The extent of the conversion of 1',2'-dihydrorotenone to metabolites 6 and 7 was estimated to be 20 and 10%, respectively, at 72 h after substrate addition. Cultures were then extracted as described above to give a brownish crude extract (30 g) which was further purified by column chromatography.
The crude extract was applied to a column (100 by 5 cm) containing 300 g of 40-200 mesh silica gel. The column was eluted with 450 ml of solvent system B at a flow rate of 4.9 ml min-' before 23-ml fractions were collected. 1',2'-Dihydrorotenone was recovered in fractions 4 through 38, but a complete separation and purification of the metabolites required several passages through silica gel columns and preparative TLC in solvent systems C, D, and E.
RESULTS
A wide range of microorganisms were initially screened to determine their abilities to metabolize rotenone. Among those that transformed rotenone, C. blakesleeana (ATCC 8688a) produced consistently higher yields of metabolites and was chosen for preparative-scale fermentation to obtain sufficient quantities of metabolites for structure elucidation.
Metabolites of rotenone. TLC of C. blakesleeana cultures transforming rotenone revealed two major metabolites, 3 and 4, and four additional minor compounds, 2, 3a, 4a, and 4b. These were isolated as described above.
Properties of metabolite 3. The analytical sample of compound 3 (Rf of 0.45 on TLC in solvent system B) was recrystallized from hot methanol to give an analytical sample of creamy white needles (11 mg) which had the following physical properties: melting point, 182 to 184°C; Xmax (CHCl3), 295 (loge 3.5); high-resolution mass spectrum mle 410.1348 (31%, calculated 410.1209 for C23H2207), mle 408 (4.9%, C23H2007), mle 395 (1.9%, C22H1907), mle 208 (35.9%, C11H1204), mle 192 (100%, C11H1203), mle 191 (30%, C11H1103), and mle 177 (14.8%, ClOH903); IR (KBr disk) OH-stretching band at 3,500 to 3,400 cm-'. The 1H-NMR spectrum was similar to that of rotenone, except for the differences noted in Table 1 . The 13C-NMR spectrum is shown in Table 2 . All of the physicochemical data obtained for this metabolite were identical to those reported for amorphigenin (5, 8) and to an authentic sample (5).
Properties of compound 3a. The analytical sample of this compound (Rf 0. 4 and mle 177 (61%, C1oH903). The 1H-NMR spectrum was similar to the spectra for rotenone and 1',2'-dihydrorotenone; major differences are reported in Table 1 , and the 13C-NMR spectrum is given in Table 2 . DISCUSSION Although the structure and stereochemistry of rotenoids have been studied extensively (6, 7, 10) , biotransformation of these abundant natural products by microorganisms has not been reported. Due to the wide use of rotenoids as pesticides and to recent interest in their use as potential antineoplastic agents (13), rotenone was selected for microbial transformation studies.
About 100 microorganisms known to transform other natural products were screened for their abilities to transform rotenone. Included in these tests were members of the genera Absidia, Allescheria, Arthrobutrys, Aspergillus (seven species), Candida, Cunninghamella (two species), Circinella, Dipodascus, Gelasinospora, Gliocladium, Mycotypha, Nematosporia, Pestalotia, Penicillium (four species), Rhodotorula, Spicaria, Streptomyces (five species), Phanerochaete, Syncephalastrum, Trichophyton and Trichothecium. Of these cultures Absidia coerulia (Ul 27B), Aspergillus terreus (UI 58), C. blakesleeana (ATCC 8688a), Trichothecium roseum (Ul 320), Penicillium vermiculatum (Ul 360), and Phanerochaete chrysosporum (UI 466) accumulated a similar array of rotenone metabolites. Only one of seven Aspergillus species, one of two Cunninghamella species, and one of four Penicillium species yielded detectable metabolites of rotenone. None of the other cultures appeared to be capable of either utilizing or accumulating metabolites of the substrate. Initial screening results were confirmed with suitable control cultures, and C. blakesleeana consistently gave the highest yields of these products and was selected for further study.
Metabolites of rotenone. Structure elucidation of the isolated metabolites was carried out by mass spectrometric, 1H-NMR, and 13C-NMR spectroscopic methods. Rotenoids display characteristic fragmentation patterns in the mass spectrometer (14, 15) . In rotenone, the base peak occurs at mle 192, corresponding to the dimethoxychroman moiety which results from cleavage at positions 12a and 6a. The second most intense fragment occurs at mle 191 (mle 192-H * ), and another abundant ion occurs at mle 177 (192-CH3).
The high-resolution mass spectrum of metabolite 3 exhibited a molecular ion at mle 410.1348 for C23H2207 consistent with the addition of an oxygen atom to the rotenone structure. The presence of the base peak at mle 192 together with mle 191 and 177 fragments indicated that modification of the rotenone structure in this metabolite had occurred at positions other than on rings A or B. Comparison of the IR spectrum of compound 3 with that of rotenone indicated the presence of an OH stretch in compound 3, and the 1H-NMR spectrum indicated that the signals for methoxyl groups and the aromatic hydrogens of rings A and D of rotenone were intact ( Table 1 ). The singlet signal for the methyl group at position 3' was replaced by a singlet at 4.25 ppm (two protons). A similar arrangement of protons was previously reported for the natural product amorphigenin (5). Conclusive evidence for the structure of this metabolite was obtained through 13C-NMR studies (8) . Comparison of the 13C-NMR spectrum of compound 3 with that of rotenone indicated that the entire ring system of rotenone was intact in compound 3 and that only the signals for the isopropylene side chain had changed; i.e., the quartet for the methyl group at position 3' occurred as a triplet downfield at 60.7 ppm, indicating the presence of a primary hydroxyl group at this position. Based on the molecular weight and empirical formula obtained by high-resolution mass spectrometry and on the 1H-and 13C-NMR spectra, compound 3 was assigned the structure of 3'-hydroxyrotenone and was fully comparable to the authentic amorphigenin (TLC, mass spectrum, IR spectrum).
Metabolite 4 exhibited a molecular ion at mle 428.14712 for C23H2408, consistent with the addition of two oxygen and two hydrogen atoms to rotenone. As in metabolite 3, the mass spectral fragmentation pattern indicated that rings A and B of rotenone were intact in compound 4 Tables 1 and 2. NMR spectrum was the same as that of 1, with the exception of signals for the olefinic side chain. In compound 4 the singlet signal for the olefin at 5.06 ppm was replaced by a singlet signal at 1.81 ppm (three protons). The 13C-NMR spectrum showed spectral differences from rotenone in carbons at the isopropylene side chain. The singlet for position 2' of rotenone at 143 ppm was replaced by another singlet at 72.9 ppm, and position 1' of rotenone at 112.6 ppm moved upfield to 65.9 ppm. These spectral changes are consistent with the addition of hydroxyl groups to both positions 1' and 2' of rotenone. On the basis of these data, metabolite 4 was identified as 1',2'-dihydro-1 ',2'-dihydroxyrotenone.
Rotenone undergoes air oxidation at positions 6a and 12a, giving rise to rotenolones (5) . In our studies, controls without microorganisms with rotenone and compounds 3 and 4 revealed the formation of rotenolones. With amorphigenin (compound 3), trace amounts of its rotenolone analog (Rf 0.4) were isolated. High-resolution mass spectrometry indicated the addition of an oxygen atom to compound 3, and the fragmentation pattern gave a base peak at mle 208 consistent with the addition of a hydroxyl group to one of the two possible positions. Metabolite 4 provided two artifacts designated 4a (Rf 0.21) and 4b (Rf 0.19). Proposed pathways for the biotransformation of rotenone by C. blakesleeana are in Fig. 1 .
Metabolites of 1',2'-dihydrorotenone. Our earlier transformations of the terpenoid antitumor compound bruceantin revealed an interesting and unusual sequence of oxidation reactions at an isopropyl group (4) . The isopropyl group of 1',2'-dihydrorotenone is functionally similar to that of bruceantin, and experiments were conducted with C. blakesleeana to determine the metabolic fate of the reduced rotenone derivative.
C. blakesleeana transformed 1',2'-dihydrorotenone into two metabolites, 6 and 7. Highresolution mass spectrometry of metabolite 6 indicated that an oxygen atom had been added to 1',2'-dihydrorotenone, but not on either ring A or B. The IR spectrum was comparable to that of 1',2'-dihydrorotenone, except for the presence of an OH-stretching band. The 13C-NMR spec-trum was identical to that of dihydrorotenone, with the exception of the signal for the 2' carbon atom. The 2' signal occurs as a doublet at 29.3 ppm in 1',2'-dihydrorotenone, but is a singlet at 71.2 ppm in metabolite 6. This spectral change is consistent with hydroxylation at position 2' to form a quaternary carbon atom. The 1H-NMR spectral data of metabolite 6 are nearly identical to those of dihydrorotenone, except for the signals for the isopropyl side-chain moiety. In dihydrorotenone these signals exist as a doublet of doublets at 0.89 to 1.0 ppm, whereas in metabolite 6 the methyl group signals for positions 3' and 1' occur as two singlets at 1.2 and 1.4 ppm, respectively. On the basis of these data, metabolite 6 was identified as 2'-hydroxy-1' ,2'-dihydrorotenone.
High-resolution mass spectrometry of metabolite 7 indicated the addition of two oxygen atoms to the structure of 1',2'-dihydrorotenone. The presence of an mle 208 base peak in the spectrum suggested the addition of a hydroxyl group to either position 6a or 12a as in the formation of rotenolones. An OH-stretching band was evident in the IR spectrum of metabolite 7, and the 13C-NMR spectrum of this compound contained a singlet signal at 67.4 ppm consistent with the addition of a hydroxyl group to the 6a position. Another singlet at 71.3 ppm is consistent with the presence of a quaternary carbon atom at position 2'. All other 1H-NMR spectral resonances were similar to those of metabolite 6, except for the presence of a singlet at 6.55 ppm (two protons) for protons at positions 7 and 4. These data show that metabolite 7 is 2',6a-dihydroxy-1',2'-dihydrorotenone and that it is an artifact since relatively large amounts of it were also produced in the control experiments without the microorganisms. This is the first report on the microbial metabolism of rotenone. It would appear that hydroxylation is a common microbial metabolic transformation with this compound. Metabolite 4 was tested against the P388 leukemia test system at the National Cancer Institute and was found inactive. Further investigations involving other metabolites are in progress.
